Altered pathways and targeted therapy in double hit lymphoma

High-grade B-cell lymphoma with translocations involving MYC and BCL2 or BCL6, usually referred to as double hit lymphoma (DHL), is an aggressive hematological malignance with distinct genetic features and poor clinical prognosis. Current standard chemoimmunotherapy fails to confer satisfying outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Yuxin, Che, Jinxin, Wu, Meijuan, Guo, Yu, Xu, Yongjin, Dong, Xiaowu, Yang, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932183/
https://www.ncbi.nlm.nih.gov/pubmed/35303910
http://dx.doi.org/10.1186/s13045-022-01249-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8932183/
https://www.ncbi.nlm.nih.gov/pubmed/35303910
http://dx.doi.org/10.1186/s13045-022-01249-9

Ejemplares similares